Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Teerlink

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
American Journal of Physiology. Renal Physiology|October 19, 2007
Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availabilityFredrik Palm, Malou Friederich, Per-Ola Carlsson, et al.
Diabetes Care|February 28, 2004
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesLise Tarnow, Peter Hovind, Tom Teerlink, et al.
Journal of Veterinary Internal Medicine|October 20, 2005
Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitationSophia Gry Moesgaard, Lotte Gam Pedersen, Tom Teerlink, et al.
Vascular Medicine (London, England)|July 30, 2013
Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilationLars Lind, Erik Ingelsson, Jitender Kumar, et al.
Clinical Chemistry|June 27, 2009
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?Roger K Schindhelm, Leonard P van der Zwan, Tom Teerlink, et al.
Analytical Biochemistry|April 13, 2002
Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatographyTom Teerlink, Robert J Nijveldt, Sigrid de Jong, et al.
Diabetes Care|December 29, 2007
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyMaria Lajer, Lise Tarnow, Anders Jorsal, et al.
Hypertension (Dallas, Tex. : 1979)|August 11, 2010
Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cellsZaiming Luo, Tom Teerlink, Kathy Griendling, et al.
Clinical and Experimental Gastroenterology|May 13, 2017
Intravenous citrulline generation test to assess intestinal function in intensive care unit patientsJob Hc Peters, Nicolette J Wierdsma, Albertus Beishuizen, et al.
FEBS Letters|September 27, 2012
Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginineMariska Davids, Joseph D T Ndika, Gajja S Salomons, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
American Journal of Physiology. Renal Physiology|October 19, 2007
Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availabilityFredrik Palm, Malou Friederich, Per-Ola Carlsson, et al.
Diabetes Care|February 28, 2004
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesLise Tarnow, Peter Hovind, Tom Teerlink, et al.
Journal of Veterinary Internal Medicine|October 20, 2005
Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitationSophia Gry Moesgaard, Lotte Gam Pedersen, Tom Teerlink, et al.
Vascular Medicine (London, England)|July 30, 2013
Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilationLars Lind, Erik Ingelsson, Jitender Kumar, et al.
Clinical Chemistry|June 27, 2009
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?Roger K Schindhelm, Leonard P van der Zwan, Tom Teerlink, et al.
Analytical Biochemistry|April 13, 2002
Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatographyTom Teerlink, Robert J Nijveldt, Sigrid de Jong, et al.
Diabetes Care|December 29, 2007
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyMaria Lajer, Lise Tarnow, Anders Jorsal, et al.
Hypertension (Dallas, Tex. : 1979)|August 11, 2010
Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cellsZaiming Luo, Tom Teerlink, Kathy Griendling, et al.
Clinical and Experimental Gastroenterology|May 13, 2017
Intravenous citrulline generation test to assess intestinal function in intensive care unit patientsJob Hc Peters, Nicolette J Wierdsma, Albertus Beishuizen, et al.
FEBS Letters|September 27, 2012
Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginineMariska Davids, Joseph D T Ndika, Gajja S Salomons, et al.
Pageof 13